What does Renalytix plc do?

Renalytix plc is a public company in the Services-Medical Laboratories industry, incorporated in X0. It is registered with the SEC under CIK 0001811115 and trades on OTC under the ticker RENXF.

What is Renalytix plc's annual revenue?

Renalytix plc reported $2.29M in revenue for fiscal year 2024, according to its 10-K filing with the SEC.

Is Renalytix plc profitable?

Renalytix plc reported a net loss of $33.46M in FY2024. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has Renalytix plc made?

Renalytix plc has filed 233 documents with the SEC since 2020. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Renalytix plc

RENXF OTC CIK: 0001811115 Services-Medical Laboratories Inc. in X0

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 233 filings →

Form	Description	Date
SCHEDULE 13D/A	—	Feb 23, 2026
EFFECT	—	Jul 30, 2025
EFFECT	—	Jul 30, 2025
EFFECT	—	Jul 30, 2025
EFFECT	—	Jul 30, 2025
EFFECT	—	Jul 30, 2025
424B3	—	Jul 30, 2025
15-12G	FORM 15-12G	Jul 30, 2025
POS AM	POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3	Jul 29, 2025
POS AM	POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3	Jul 29, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Renalytix plc. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Revenue: $2.29M (FY2024)
Net Income: ($33.46M) (FY2024)
Total Assets: $7.97M (FY2024)
Operating Income: ($29.61M)

Full financials →

Details

CIK: 0001811115
Ticker: RENXF
Exchange: OTC
Incorporated: X0
First Filing: 2020
Total Filings: 233

Services-Medical Laboratories rankings →